Clinical efficacy and safety of the BAT1706 (proposed bevacizumab biosimilar) compared with reference bevacizumab in patients with advanced nonsquamous NSCLC: A randomized, double-blind, phase III study.
Tarih
2022Yazar
Chen, Likun
Trukhin, Dmytro
Kolesnik, Oleksii
David Gomez Rangel, Jose David
Cil, Timucin
Li, Xingya
Cicin, Irfan
Kobziev, Oleh
Shen, Yihong
Liu, Zhihua
Oleksandr, Ivashchuk
Ozyilkan, Ozgur
Igor, Bondarenko
Ursol, Grygorii
Chen, Jun
Oleksandr, Kostiuk
Chen, Zhendong
Zhang, Helong
Tural, Deniz
Zhang, Li